PMC:7402624 / 25419-25686 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T202","span":{"begin":88,"end":95},"obj":"Body_part"},{"id":"T203","span":{"begin":241,"end":247},"obj":"Body_part"}],"attributes":[{"id":"A202","pred":"fma_id","subj":"T202","obj":"http://purl.org/sig/ont/fma/fma241992"},{"id":"A203","pred":"fma_id","subj":"T203","obj":"http://purl.org/sig/ont/fma/fma62970"}],"text":"Following stimulation in vitro, PBMC from COVID-19 patients produced more CCL2, CXCL10, eotaxin, and IL-1RA than HD (fig. S4, C and D) and concentrations of CXCL10 and CCL2 correlated between the matched supernatant from stimulated PBMC and plasma samples (fig. S4E)."}

{"project":"LitCovid-PubTator","denotations":[{"id":"922","span":{"begin":74,"end":78},"obj":"Gene"},{"id":"923","span":{"begin":80,"end":86},"obj":"Gene"},{"id":"924","span":{"begin":88,"end":95},"obj":"Gene"},{"id":"925","span":{"begin":101,"end":107},"obj":"Gene"},{"id":"926","span":{"begin":157,"end":163},"obj":"Gene"},{"id":"927","span":{"begin":168,"end":172},"obj":"Gene"},{"id":"939","span":{"begin":51,"end":59},"obj":"Species"},{"id":"953","span":{"begin":42,"end":50},"obj":"Disease"},{"id":"954","span":{"begin":113,"end":115},"obj":"Disease"}],"attributes":[{"id":"A922","pred":"tao:has_database_id","subj":"922","obj":"Gene:6347"},{"id":"A923","pred":"tao:has_database_id","subj":"923","obj":"Gene:3627"},{"id":"A924","pred":"tao:has_database_id","subj":"924","obj":"Gene:6356"},{"id":"A925","pred":"tao:has_database_id","subj":"925","obj":"Gene:3557"},{"id":"A926","pred":"tao:has_database_id","subj":"926","obj":"Gene:3627"},{"id":"A927","pred":"tao:has_database_id","subj":"927","obj":"Gene:6347"},{"id":"A939","pred":"tao:has_database_id","subj":"939","obj":"Tax:9606"},{"id":"A953","pred":"tao:has_database_id","subj":"953","obj":"MESH:C000657245"},{"id":"A954","pred":"tao:has_database_id","subj":"954","obj":"MESH:D006816"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Following stimulation in vitro, PBMC from COVID-19 patients produced more CCL2, CXCL10, eotaxin, and IL-1RA than HD (fig. S4, C and D) and concentrations of CXCL10 and CCL2 correlated between the matched supernatant from stimulated PBMC and plasma samples (fig. S4E)."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T184","span":{"begin":42,"end":50},"obj":"Disease"},{"id":"T185","span":{"begin":113,"end":115},"obj":"Disease"}],"attributes":[{"id":"A184","pred":"mondo_id","subj":"T184","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A185","pred":"mondo_id","subj":"T185","obj":"http://purl.obolibrary.org/obo/MONDO_0007739"}],"text":"Following stimulation in vitro, PBMC from COVID-19 patients produced more CCL2, CXCL10, eotaxin, and IL-1RA than HD (fig. S4, C and D) and concentrations of CXCL10 and CCL2 correlated between the matched supernatant from stimulated PBMC and plasma samples (fig. S4E)."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T453","span":{"begin":241,"end":247},"obj":"http://purl.obolibrary.org/obo/UBERON_0001969"}],"text":"Following stimulation in vitro, PBMC from COVID-19 patients produced more CCL2, CXCL10, eotaxin, and IL-1RA than HD (fig. S4, C and D) and concentrations of CXCL10 and CCL2 correlated between the matched supernatant from stimulated PBMC and plasma samples (fig. S4E)."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T155","span":{"begin":80,"end":86},"obj":"Chemical"},{"id":"T156","span":{"begin":101,"end":103},"obj":"Chemical"},{"id":"T158","span":{"begin":113,"end":115},"obj":"Chemical"},{"id":"T159","span":{"begin":122,"end":124},"obj":"Chemical"},{"id":"T160","span":{"begin":157,"end":163},"obj":"Chemical"}],"attributes":[{"id":"A155","pred":"chebi_id","subj":"T155","obj":"http://purl.obolibrary.org/obo/CHEBI_138157"},{"id":"A156","pred":"chebi_id","subj":"T156","obj":"http://purl.obolibrary.org/obo/CHEBI_63895"},{"id":"A157","pred":"chebi_id","subj":"T156","obj":"http://purl.obolibrary.org/obo/CHEBI_74072"},{"id":"A158","pred":"chebi_id","subj":"T158","obj":"http://purl.obolibrary.org/obo/CHEBI_73925"},{"id":"A159","pred":"chebi_id","subj":"T159","obj":"http://purl.obolibrary.org/obo/CHEBI_29401"},{"id":"A160","pred":"chebi_id","subj":"T160","obj":"http://purl.obolibrary.org/obo/CHEBI_138157"}],"text":"Following stimulation in vitro, PBMC from COVID-19 patients produced more CCL2, CXCL10, eotaxin, and IL-1RA than HD (fig. S4, C and D) and concentrations of CXCL10 and CCL2 correlated between the matched supernatant from stimulated PBMC and plasma samples (fig. S4E)."}

{"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T62","span":{"begin":101,"end":107},"obj":"http://purl.obolibrary.org/obo/GO_0005152"}],"text":"Following stimulation in vitro, PBMC from COVID-19 patients produced more CCL2, CXCL10, eotaxin, and IL-1RA than HD (fig. S4, C and D) and concentrations of CXCL10 and CCL2 correlated between the matched supernatant from stimulated PBMC and plasma samples (fig. S4E)."}

{"project":"LitCovid-sentences","denotations":[{"id":"T153","span":{"begin":0,"end":267},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Following stimulation in vitro, PBMC from COVID-19 patients produced more CCL2, CXCL10, eotaxin, and IL-1RA than HD (fig. S4, C and D) and concentrations of CXCL10 and CCL2 correlated between the matched supernatant from stimulated PBMC and plasma samples (fig. S4E)."}